<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00999765</url>
  </required_header>
  <id_info>
    <org_study_id>BD-MBCT</org_study_id>
    <nct_id>NCT00999765</nct_id>
  </id_info>
  <brief_title>Pilot Study: Mindfulness-Based Cognitive Therapy as a Tool for Prophylactic Mood Stabilizing Therapy in Bipolar Disorder</brief_title>
  <official_title>Pilot Study: Mindfulness-Based Cognitive Therapy as a Tool for Prophylactic Mood Stabilizing Therapy in Bipolar Disorder</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Douglas Mental Health University Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Douglas Mental Health University Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the feasibility and short-term efficacy of MBCT as
      an add-on (i.e. patients must be stable with their regular mood stabilizing medication) for
      the maintenance therapy of bipolar disorder.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>June 2008</start_date>
  <completion_date type="Anticipated">December 2012</completion_date>
  <primary_completion_date type="Actual">March 2010</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>number of weeks in which criteria are meet for a mood episode evaluate with the Longitudinal Interval Follow-up Evaluation (LIFE)</measure>
    <time_frame>12 weeks (4 weeks post treatment)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in intensity of subsyndromal symptoms of depression on the HAM-D 29 scale</measure>
    <time_frame>2, 4, 6, 8 and 12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in intensity of subsyndromal symptoms of depression on the MADRS scale</measure>
    <time_frame>2, 4, 6, 8 and 12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in intensity of subsyndromal symptoms of hypomania on the YMRS scale</measure>
    <time_frame>2, 4, 6, 8 and 12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change id intensity in subsyndromal symptoms of anxiety on the HAM-A scale</measure>
    <time_frame>2,4,6,8 and 12 weeks</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">36</enrollment>
  <condition>Bipolar Disorder</condition>
  <arm_group>
    <arm_group_label>Bipolar Disorder - stable</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Mindfulness-Based Cognitive Therapy</intervention_name>
    <description>eight-week (two hours a week) group therapy (8-12 patients per group)</description>
    <arm_group_label>Bipolar Disorder - stable</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Bipolar Disorder of third-line bipolar disorders program
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Males or females (&gt;18 years old)

          -  Bipolar disorder (as per the Structured Clinical Interview for DSM Disorders
             (SCID)(22)), euthymic state: Complete remission for at least four weeks ((Montgomery
             and Asberg Rating Scale (MADRS) ≤ 6 and item-1 (depressed mood) = 0 and no suicidal
             ideations (MADRS(item-10) &lt; 4)

          -  Must have had at least 3 depressive phases in the last 5 years

          -  Cooperative and willing to complete all the aspects of the study and especially the 45
             minutes of exercise per day

          -  Must have completed a Secondary V (11th grade) education

        Exclusion Criteria:

          -  Other active psychiatric disorders (as per the SCID)

          -  Rapid cycling

          -  Bipolar disorder secondary to a medical condition or substance-induced mood disorder

          -  Suicidal ideations (MADRS(item 10)&gt;3)

          -  Active i.e. unstable and/or untreated medical condition

          -  Substance abuse (defined as per DSM-IV) in the last four weeks

          -  CBT (No more than four sessions (ever))

          -  Previous participation in a psychoeducation group within the last 6 months

          -  Current other psychotherapy (more than once a month)

          -  Practice of meditation (more than once a month) during the last two years

          -  Practice of yoga (more than once a week) during the last year

          -  Previous participation in a MBSR group

          -  Electroconvulsive Therapy (ECT) within the last three months
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Serge Beaulieu, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Douglas Mental Health University Institute / McGill</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Douglas Mental Health University Institute</name>
      <address>
        <city>Montréal</city>
        <state>Quebec</state>
        <zip>H4H 1R3</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>January 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 21, 2009</study_first_submitted>
  <study_first_submitted_qc>October 21, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 22, 2009</study_first_posted>
  <last_update_submitted>January 30, 2012</last_update_submitted>
  <last_update_submitted_qc>January 30, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 31, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Douglas Mental Health University Institute</investigator_affiliation>
    <investigator_full_name>Serge Beaulieu</investigator_full_name>
    <investigator_title>Serge Beaulieu</investigator_title>
  </responsible_party>
  <keyword>Bipolar Disorder</keyword>
  <keyword>Bipolar Depression</keyword>
  <keyword>Mindfulness-Based Cognitive Therapy</keyword>
  <keyword>MBCT</keyword>
  <keyword>Maintenance</keyword>
  <keyword>Euthymic</keyword>
  <keyword>Efficacy</keyword>
  <keyword>Feasibility</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Disease</mesh_term>
    <mesh_term>Bipolar Disorder</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

